In patients with axial spondyloarthritis (axSpA), chronic back pain typically manifests itself for the first time before the age of 45. Timely referral to rheumatology specialists and close monitoring of symptoms in patients already diagnosed with axSpA help to ensure that patients achieve adequate disease control. Although NSAIDs are still considered first-line therapy, there are now several highly effective treatment alternatives for patients who do not respond adequately.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Sarcoidosis, echinococcosis & Co.
Suspected symptoms and differential diagnoses
- Cancer prevention
Constant dripping – alcohol and cancer
- Steatotic liver disease
GLP-1RA in MASH – what’s new?
- Chronic pruritus: “Tour d'horizon”
Focus on new anti-inflammatory therapeutic approaches
- Multiple sclerosis
Unexpected side effects when switching from natalizumab to a biosimilar
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Immunotherapy
Subcutaneously or intravenously?
- Work-related asthma